Insulet Corp (PODD) stock
PODDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 21/3046% below fair value
$150.03+1.97 (+1.33%)
Close on Nov 11, 2026Market cap $10.41BP/E 24.4Yield –
Insulet cash
Cash and short-term investments held at the end of each period.
Insulet's cash was $584.40M at Sep 30, 2026. For fiscal 2025 it was $716.10M, down 24.9% from the year before. Over ten years it grew 19.3% a year on average. The highest annual figure on record is $962.40M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $716.10M | -24.9% |
| FY2024 | Dec 31, 2024 | $953.40M | +35.4% |
| FY2023 | Dec 31, 2023 | $704.20M | +2.1% |
| FY2022 | Dec 31, 2022 | $689.80M | -14.5% |
| FY2021 | Dec 31, 2021 | $806.40M | -16.2% |
| FY2020 | Dec 31, 2020 | $962.40M | +155.9% |
| FY2019 | Dec 31, 2019 | $376.10M | +30.2% |
| FY2018 | Dec 31, 2018 | $288.90M | +6.0% |
| FY2017 | Dec 31, 2017 | $272.60M | +98.7% |
| FY2016 | Dec 31, 2016 | $137.20M | +11.8% |
| FY2015 | Dec 31, 2015 | $122.67M | -18.9% |
| FY2014 | Dec 31, 2014 | $151.19M | +1.0% |
| FY2013 | Dec 31, 2013 | $149.73M | +161.3% |
| FY2012 | Dec 31, 2012 | $57.29M | -39.0% |
| FY2011 | Dec 31, 2011 | $93.96M | -17.1% |
| FY2010 | Dec 31, 2010 | $113.27M | -11.5% |
| FY2009 | Dec 31, 2009 | $128.00M | +125.9% |
| FY2008 | Dec 31, 2008 | $56.66M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $584.40M | -22.8% |
| Q2 FY2026 | Jun 30, 2026 | $534.90M | -52.3% |
| Q1 FY2026 | Mar 31, 2026 | $480.40M | -62.6% |
| Q4 FY2025 | Dec 31, 2025 | $716.10M | -24.9% |
| Q3 FY2025 | Sep 30, 2025 | $757.40M | -16.1% |
| Q2 FY2025 | Jun 30, 2025 | $1.12B | +36.6% |
| Q1 FY2025 | Mar 31, 2025 | $1.28B | +70.8% |
| Q4 FY2024 | Dec 31, 2024 | $953.40M | +35.4% |
| Q3 FY2024 | Sep 30, 2024 | $902.60M | +31.7% |
| Q2 FY2024 | Jun 30, 2024 | $821.00M | +24.4% |
| Q1 FY2024 | Mar 31, 2024 | $751.20M | +18.1% |
| Q4 FY2023 | Dec 31, 2023 | $704.20M | +2.1% |
| Q3 FY2023 | Sep 30, 2023 | $685.40M | -7.0% |
| Q2 FY2023 | Jun 30, 2023 | $660.10M | -8.8% |
| Q1 FY2023 | Mar 31, 2023 | $635.90M | -12.3% |
| Q4 FY2022 | Dec 31, 2022 | $689.80M | -14.5% |
| Q3 FY2022 | Sep 30, 2022 | $737.10M | -15.5% |
| Q2 FY2022 | Jun 30, 2022 | $723.80M | -18.4% |
| Q1 FY2022 | Mar 31, 2022 | $724.90M | -16.2% |
| Q4 FY2021 | Dec 31, 2021 | $806.40M | -16.2% |
| Q3 FY2021 | Sep 30, 2021 | $871.90M | -2.8% |
| Q2 FY2021 | Jun 30, 2021 | $886.90M | +5.0% |
| Q1 FY2021 | Mar 31, 2021 | $865.00M | +169.0% |
| Q4 FY2020 | Dec 31, 2020 | $962.40M | +155.9% |
| Q3 FY2020 | Sep 30, 2020 | $896.70M | +48.1% |
| Q2 FY2020 | Jun 30, 2020 | $844.40M | +172.6% |
| Q1 FY2020 | Mar 31, 2020 | $321.60M | +148.7% |
| Q4 FY2019 | Dec 31, 2019 | $376.10M | +30.2% |
| Q3 FY2019 | Sep 30, 2019 | $605.52M | +378.4% |
| Q2 FY2019 | Jun 30, 2019 | $309.78M | +127.4% |
| Q1 FY2019 | Mar 31, 2019 | $129.30M | -36.4% |
| Q4 FY2018 | Dec 31, 2018 | $288.90M | +6.0% |
| Q3 FY2018 | Sep 30, 2018 | $126.56M | +23.8% |
| Q2 FY2018 | Jun 30, 2018 | $136.25M | +85.4% |
| Q1 FY2018 | Mar 31, 2018 | $203.15M | +167.2% |
| Q4 FY2017 | Dec 31, 2017 | $272.60M | +98.7% |
| Q3 FY2017 | Sep 30, 2017 | $102.23M | – |
| Q2 FY2017 | Jun 30, 2017 | $73.49M | – |
| Q1 FY2017 | Mar 31, 2017 | $76.04M | – |
| Q4 FY2016 | Dec 31, 2016 | $137.20M | – |
See a number that looks wrong?